Across more than 100 preclinical publications many from a single research group led by Sikiri and colleagues the peptide has demonstrated healing effects on tendon, muscle, bone, nerve, and gut tissue, often with no reported acute toxicity even at doses far exceeding those proposed for practical use
The physicochemical stability of BPC-157 across various biological environments may contribute to its apparent safety profile, as the peptide appears to be well-tolerated when administered via different routes including oral, subcutaneous, and intramuscular administration
Quadrupling the dose did not buy a meaningful gain
FIGURE 2 3 Redox dysregulation in disease states 3.1 GSH in peripheral immune cell infiltration Several studies indicate that neuroinflammatory changes associated with neurodegeneration compromise the BBB or its function by disrupting transport systems, facilitating the infiltration of immune cells, and influencing the BBBs role as a signaling interface
Competition for metabolic enzymes could theoretically alter the blood levels of either BPC-157 or the competing medication